Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00280
Full Text
Open PDFAbstract
Available in full text
Date
July 27, 2018
Authors
Publisher
Frontiers Media SA